178 related articles for article (PubMed ID: 4996911)
1. [Application of carbenicillin in the Gram-negative infections].
Danieli G; Montroni M
Clin Ter; 1971 Apr; 57(1):49-62. PubMed ID: 4996911
[No Abstract] [Full Text] [Related]
2. [Carbenicillin. Current data on its use].
Bertoye A; Woehrle R
Lyon Med; 1971; 225():Suppl:137-41. PubMed ID: 5564793
[No Abstract] [Full Text] [Related]
3. Pseudomonas aeruginosa and proteus infections in premature babies and in infants. Therapeutic trial with carbenicillin.
Korányi G; Pesti E; Somogyi G
Acta Paediatr Acad Sci Hung; 1970; 11(2):141-50. PubMed ID: 4994152
[No Abstract] [Full Text] [Related]
4. [Bacteriological studies of carbenicillin].
Nakazawa S; Ono H; Wajima G; Izawa T
Jpn J Antibiot; 1972 Feb; 25(1):21-7. PubMed ID: 4337674
[No Abstract] [Full Text] [Related]
5. [Effect of carbenicillin against some microorganisms. Microbiological and electron microscopic studies].
Jedlicková Z; Rýc M
Arzneimittelforschung; 1969 Sep; 19(9):1513-7. PubMed ID: 4981209
[No Abstract] [Full Text] [Related]
6. Carbenicillin in the treatment of the critically ill patient.
Holloway WJ; Taylor WA
Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):338-41. PubMed ID: 4931416
[No Abstract] [Full Text] [Related]
7. Carbenicillin (Pyopen) in treatment of severe systemic infections and pyelonephritis due to Pseudomonas aeruginosa and Proteus.
Liwski R; Gietko G
Pol Med J; 1970; 9(3):611-20. PubMed ID: 4989147
[No Abstract] [Full Text] [Related]
8. Evaluation of gentamicin with carbenicillin in infections due to gram-negative bacilli.
Klastersky J; Cappel R; Debusscher L
Curr Ther Res Clin Exp; 1971 Mar; 13(3):174-81. PubMed ID: 4998289
[No Abstract] [Full Text] [Related]
9. [In vitro action and clinical use of indanyl carbenicillin].
Fontana G; Laudi M; Sesia G; Savoia D; Cauda F
Minerva Urol; 1976; 28(6):285-8. PubMed ID: 827680
[No Abstract] [Full Text] [Related]
10. Carbenicillin--gentamicin.
Osler DC; Rutsky EA; Schimpff SC
N Engl J Med; 1971 Aug; 285(7):411-2. PubMed ID: 4997377
[No Abstract] [Full Text] [Related]
11. [Comparative study of the chemotherapeutic effect of ampicillin and carbenicillin].
Petrova MA; Fomina IP; Kuznetsova SM; Samoĭlova LN
Antibiotiki; 1973 Jan; 18(1):34-8. PubMed ID: 4631001
[No Abstract] [Full Text] [Related]
12. [Pseudomonas aeruginosa sensitivity to boric acid, carbenicillin and deposul and their potential use in treating Pseudomonas aeruginosa infection].
Litovchenko PP; Chernobrovyĭ NP; Shataliuk BP; Zavialets IT
Mikrobiol Zh (1978); 1981; 43(3):369-72. PubMed ID: 6789042
[No Abstract] [Full Text] [Related]
13. Ticarcillin.
Med Lett Drugs Ther; 1977 Feb; 19(4):17-8. PubMed ID: 402545
[No Abstract] [Full Text] [Related]
14. [Carbecillin therapy of pseudomonas aeruginosa and proteus infections in infancy].
Korányi G; Pesti E
Orv Hetil; 1972 Jul; 113(30):1779-84. PubMed ID: 5043096
[No Abstract] [Full Text] [Related]
15. Bacteriological, pharmacological, and clinical studies of carbenicillin.
Meyers BR; Sabbaj J; Weinstein L
Arch Intern Med; 1970 Feb; 125(2):282-6. PubMed ID: 4983746
[No Abstract] [Full Text] [Related]
16. [Clinical trials of carbenicillin therapy in infections due to Pseudomonas aeruginosa].
Malfatti S; Pardini C; Silvi G
G Mal Infett Parassit; 1971 Nov; 23(11):1063-8. PubMed ID: 5004853
[No Abstract] [Full Text] [Related]
17. [Effective treatment of urinary tract infection with carbenicillin].
Yamamoto C; Miyoshi T; Namikawa K; Fukuchi S
Hinyokika Kiyo; 1971 Sep; 17(9):596-600. PubMed ID: 5001081
[No Abstract] [Full Text] [Related]
18. Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia.
Schimpff S; Satterlee W; Young VM; Serpick A
N Engl J Med; 1971 May; 284(19):1061-5. PubMed ID: 4994878
[No Abstract] [Full Text] [Related]
19. [1st personal experiences with carbenicillin therapy of urinary tract infections due to Pseudomonas aeruginosa].
De Rosa F
G Mal Infett Parassit; 1971 Nov; 23(11):1068-70. PubMed ID: 5004854
[No Abstract] [Full Text] [Related]
20. Comparison between carbenicillin and a -carboxyl-3-thienylmethyl penicillin (BRL 2288), a new semisynthetic penicillin active against Pseudomonas aeruginosa.
Klastersky J; Daneau D
Curr Ther Res Clin Exp; 1972 Aug; 14(8):503-9. PubMed ID: 4629312
[No Abstract] [Full Text] [Related]
[Next] [New Search]
